Anne‐Laure Martin

Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial

Henri Roché, P. Fumoleau, M. Spielmann et al. · Journal of Clinical Oncology · 2006 · 570 citations · Full text

A refined molecular taxonomy of breast cancer

Mickaël Guedj, Laëtitia Marisa, Aurélien de Reyniès et al. · Oncogene · 2011 · 271 citations · Full text

Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer

Frédérique Penault‐Llorca, Fabrice André, Christine Sagan et al. · Journal of Clinical Oncology · 2009 · 238 citations · Full text

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Karim Fizazi, Laura Faivre, F. Lesaunier et al. · The Lancet Oncology · 2015 · 236 citations

Urology, Getug 12, Genitourinary Cancer +8

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis

Arlindo R. Ferreira, Antonio Di Meglio, Barbara Pistilli et al. · Annals of Oncology · 2019 · 212 citations · Full text

Nursing, Quality Of Life, Differential Impact +11